Inventor · disambiguated record
Michael J. Zelesko
Also filed as: ZELESKO MICHAEL J · ZELESKO MICHAEL JOHN
7 granted patents·1 pending application·207 citations·filing 1976–2004
87Inventor score
Top patents by PatentIndex Score
8 records- 0194US6734194B2Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferationJANSSEN PHARMACEUTICA NV·Filed 2003·Granted May 11, 2004·67 cites·7 claims
- 0293US6743805B2Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferationJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Jun 1, 2004·59 cites·5 claims
- 0390US4059583ASubstituted indolesMCNEILAB INC·Filed 1976·Granted Nov 22, 1977·23 cites·35 claims
- 0484US7253183B2Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferationJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Aug 7, 2007·17 cites·8 claims
- 0580US6365600B1(Imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferationJANSSEN PHARMACEUTICA NV·Filed 1999·Granted Apr 2, 2002·40 cites·8 claims
- 0651US2004157882A1Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferationFiled 2003·Application pending·0 cites
- 0731US4725604AMethods for the treatment of ventricular dysrhythmia and prevention of ventricular fibrillationMCNEILAB INC·Filed 1986·Granted Feb 16, 1988·1 cites·14 claims
- 0824US4584302AMethods for the treatment of ventricular dysrhythmia and prevention of ventricular fibrillationMCNEILAB INC·Filed 1983·Granted Apr 22, 1986·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Michael J. Zelesko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →